L'insulinothérapie hebdomadaire : un changement de paradigme dans la prise en charge du diabète
Year: 2024
Type: dissertation
Abstract: Weekly insulin therapy represents a breakthrough in diabetes management, offering an alternative to daily injections that enhances patient adherence. Insulins icodec (Novo Nordisk) and efsitora alfa (Eli Lilly), now through phase 3 trials, show similar effectiveness to daily basal insulins, reducing injections from 365 to 52 annually without increasing hypoglycemia risks. This innovation simplifies diabetes management, significantly improving patient quality of life by lessening the frequency of injections and mental burden. With a promising future in transforming diabetes care, weekly insulin therapy stands to become a cornerstone in patient support, empowering them with greater autonomy and comfort.
Source: HAL
Author: Ngami, Jessy
Institution: Université de Caen Normandie
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7001904291
